Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell therapy in ischemic heart disease.

Julia N E Sunkomat1, Mohamed A Gaballa

  • 1University of Arizona Sarver Heart Center, Section of Cardiology, Tucson, AZ 85624, USA.

Cardiovascular Drug Reviews
|December 4, 2003
PubMed
Summary

Stem cell therapy shows promise for treating cardiovascular diseases, including coronary artery disease and heart failure. Further research is needed to optimize patient selection, cell type, delivery, and dosage for effective and safe cardiac repair.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transplantation of Epigenetically Modified Adult Cardiac c-Kit+ Cells Retards Remodeling and Improves Cardiac Function in Ischemic Heart Failure Model.

Stem cells translational medicine·2015
Same author

Inhibition of nitric oxide synthases, but not inducible nitric oxide synthase, selectively worsens left ventricular function after successful resuscitation from cardiac arrest in swine.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine·2015
Same author

HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation.

Fibrogenesis & tissue repair·2014
Same author

Retrograde coronary vein infusion of cardiac explant-derived c-Kit+ cells improves function in ischemic heart failure.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2014
Same author

An electrically coupled tissue-engineered cardiomyocyte scaffold improves cardiac function in rats with chronic heart failure.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2014
Same author

Chronic heart failure is associated with transforming growth factor beta-dependent yield and functional decline in atrial explant-derived c-Kit+ cells.

Journal of the American Heart Association·2013

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality globally.
  • Sequelae of CAD, such as myocardial infarction and congestive heart failure (CHF), significantly impact patient quality of life and healthcare costs.
  • Stem cell therapy is emerging as a highly active research area in cardiology due to its potential for neovascularization and improved cardiac function.

Purpose of the Study:

  • To provide a systematic overview of the science behind stem cells and their effects on ischemic myocardium.
  • To highlight the potential of stem cell therapy in treating various cardiovascular conditions.
  • To identify key challenges and questions that need to be addressed for the clinical application of stem cell therapy.

Main Methods:

Related Experiment Videos

  • Review of published studies on stem cell transplantation in myocardial infarction models.
  • Analysis of variations in experimental designs, including ischemia models, donor/recipient species, cell delivery techniques, cell types, cell numbers, and timing.
  • Systematic overview of the scientific literature concerning stem cell effects in ischemic myocardium.

Main Results:

  • Published studies, despite design variations, consistently highlight the potential of stem cell therapy in cardiovascular disease treatment.
  • Stem cells may contribute to neovascularization and improve cardiac function post-myocardial infarction.
  • Stem cell therapy's applications extend beyond ischemic heart disease to non-ischemic cardiomyopathy, peripheral vascular disease, and aging.

Conclusions:

  • Stem cell therapy holds significant promise for revolutionizing heart failure treatment and managing cardiovascular diseases.
  • Key obstacles, including patient selection, optimal cell type, delivery route, dosage, and comparative efficacy/safety, require further investigation.
  • Stem cells offer potential as gene therapy vectors and can be integrated with existing therapeutic modalities to improve patient outcomes.